In silico screening and molecular docking study of quinoline based compounds with Human kallikrein 7 in complex with 1,4-diazepane-7-one 1-acetamide derivative receptor target for potential antibacterials
Abstract
The quinolines based drugs and its analogues are widely used as a medicinal drug. In this study, five compounds from quinoline-based pharmaceuticals have been discovered using virtual screening with Autodock software, with binding affinities ranging from 6.6 to 5.4 kcal/mol. The best suitable chemical is levofloxacin, which has a higher drug-likeness and a total drug score of 0.87. Improved receptor (kallikrein 7) Vander-waal bonding with ARG A:50, TRP A:51, LYS A:243, ASN A:239, ASN A:48 is also revealed by levofloxacin docking and bonding studies. Based on the affinity score, levofloxacin was found to have superior pharmacological properties and bonding when compared to other molecules from quinoline-based drugs and kallikrein 7. After thorough in silico research, levofloxacin from quinoline-based medications can be used as a potential treatment target towards development of antibiotic medicine. URN:NBN:sciencein.jmc.2023.585
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.